Narongsak Nakwan1, Suksham Jain2, Kishore Kumar3, Shigeharu Hosono4,5, Majeda Hammoud6, Yasser Yahia Elsayed6, Shabina Ariff7, Babar Hasan7, Waqar Khowaja7, Woei Bing Poon8. 1. Department of Pediatrics, Hat Yai Medical Education Center, Hat Yai Hospital, Songkhla, Thailand. 2. Department of Pediatrics, Govt. Medical College and Hospital, Chandigarh, India. 3. Department of Pediatrics, Cloudnine Hospital, Bangalore, India. 4. Division of Neonatology, Department of Perinatal and Neonatal Medicine, Jichi Medical University, Saitama, Japan. 5. Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan. 6. Department of Pediatrics and Neonatology, Faculty of Medicine, Kuwait University and Al-Sabah Maternity Hospital, Kuwait. 7. Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. 8. Department of Neonatal and Developmental Medicine, Singapore General Hospital, Singapore.
Abstract
Objectives: To explore the incidence, etiologies, diagnostic methods, treatment options and outcomes in neonates with persistent pulmonary hypertension of the newborn (PPHN) and to identify mortality risk factors in a study from six Asian countries. Methods: A retrospective chart review of patients with documented PPHN from seven centers in six Asian countries (Japan, Kuwait, India, Pakistan, Singapore, and Thailand) between 1 January, 2014 and 31 December, 2016, was performed. Results: A total of 369 PPHN infants were identified. The incidence of PPHN ranged from 1.2 to 4.6 per 1000 live births. The all-cause mortality rate was 20.6% (76 of 369). Meconium aspiration syndrome was the primary cause of PPHN (24.1%). In most cases (84.8%) echocardiography was used to establish the diagnosis of PPHN. Sildenafil was the most commonly used pulmonary vasodilator (51.2%). Multivariate multiple regression analysis indicated gestational age <34 weeks (adjusted odds ratio (OR) = 3.27; 95% CI 1.56-6.74), congenital diaphragmatic hernia (CDH)/lung hypoplasia (LH) (adjusted OR = 6.13 (95% CI 2.28-16.42)), treatment with high frequency oscillation ventilation (HFOV) with or without inhaled nitric oxide (iNO) (adjusted OR = 3.11 (95% CI 1.52-6.34)), and inotropic agents (adjusted OR = 9.43 (95% CI 2.71-32.83)) were independently associated with increased risk of death.Conclusions: The incidence of PPHN in the current study was higher than in western settings. Birth weight, gestational age, CDH/LH, HFOV/iNO, and inotropic agents were significant mortality risk factors.
Objectives: To explore the incidence, etiologies, diagnostic methods, treatment options and outcomes in neonates with persistent pulmonary hypertension of the newborn (PPHN) and to identify mortality risk factors in a study from six Asian countries. Methods: A retrospective chart review of patients with documented PPHN from seven centers in six Asian countries (Japan, Kuwait, India, Pakistan, Singapore, and Thailand) between 1 January, 2014 and 31 December, 2016, was performed. Results: A total of 369 PPHN infants were identified. The incidence of PPHN ranged from 1.2 to 4.6 per 1000 live births. The all-cause mortality rate was 20.6% (76 of 369). Meconium aspiration syndrome was the primary cause of PPHN (24.1%). In most cases (84.8%) echocardiography was used to establish the diagnosis of PPHN. Sildenafil was the most commonly used pulmonary vasodilator (51.2%). Multivariate multiple regression analysis indicated gestational age <34 weeks (adjusted odds ratio (OR) = 3.27; 95% CI 1.56-6.74), congenital diaphragmatic hernia (CDH)/lung hypoplasia (LH) (adjusted OR = 6.13 (95% CI 2.28-16.42)), treatment with high frequency oscillation ventilation (HFOV) with or without inhaled nitric oxide (iNO) (adjusted OR = 3.11 (95% CI 1.52-6.34)), and inotropic agents (adjusted OR = 9.43 (95% CI 2.71-32.83)) were independently associated with increased risk of death.Conclusions: The incidence of PPHN in the current study was higher than in western settings. Birth weight, gestational age, CDH/LH, HFOV/iNO, and inotropic agents were significant mortality risk factors.
Entities:
Keywords:
Asian country; developing country; multicenter retrospective study; newborn; persistent pulmonary hypertension of the newborn
Authors: Muhammad Sohail Arshad; Mudasser Adnan; Hafiz Muhammad Anwar-Ul-Haq; Arif Zulqarnain Journal: Pak J Med Sci Date: 2021 Sep-Oct Impact factor: 1.088
Authors: Yuwei Zhao; Lei Liang; Guanghui Liu; Hong Zheng; Liying Dai; Yan Wang; Lei Wang; Weiting Sheng Journal: Front Pediatr Date: 2021-05-20 Impact factor: 3.418